No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs565404921 |
chr10:548153-548154 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs568406916 |
chr10:548240-548241 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs114456966 |
chr10:548248-548249 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs566926742 |
chr10:548265-548266 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs539137688 |
chr10:548274-548275 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs187666383 |
chr10:548277-548278 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs534067760 |
chr10:548280-548281 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs149471448 |
chr10:548351-548352 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs72774532 |
chr10:548362-548363 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs557201045 |
chr10:548368-548369 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs577087578 |
chr10:548388-548389 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs816595 |
chr10:548389-548390 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs372983879 |
chr10:548453-548454 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs536413055 |
chr10:548465-548466 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs193011929 |
chr10:548477-548478 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs184827065 |
chr10:548481-548482 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs189719103 |
chr10:548498-548499 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs566813468 |
chr10:548501-548502 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs144608949 |
chr10:548542-548543 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs564680756 |
chr10:548547-548548 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs192418018 |
chr10:548560-548561 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs543838212 |
chr10:548591-548592 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs561590751 |
chr10:548600-548601 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs373667153 |
chr10:548616-548617 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs530346415 |
chr10:548640-548641 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs183729935 |
chr10:548642-548643 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs539612374 |
chr10:548662-548663 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs372504685 |
chr10:548681-548682 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs532794421 |
chr10:548691-548692 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs552700983 |
chr10:548718-548719 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs188097711 |
chr10:548799-548800 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs538228248 |
chr10:548831-548832 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs138510715 |
chr10:548841-548842 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs548308871 |
chr10:548845-548846 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs567524243 |
chr10:548871-548872 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs536161577 |
chr10:548888-548889 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs377443509 |
chr10:548895-548896 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs816594 |
chr10:548917-548918 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs142267971 |
chr10:548933-548934 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs538494046 |
chr10:548940-548941 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs182013067 |
chr10:548942-548943 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs575715875 |
chr10:548964-548965 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs574735845 |
chr10:549002-549003 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs575008863 |
chr10:549040-549041 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs543775277 |
chr10:549072-549073 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs146386437 |
chr10:549073-549074 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs575035516 |
chr10:549097-549098 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs117736447 |
chr10:549106-549107 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs560886002 |
chr10:549109-549110 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs532135068 |
chr10:549118-549119 |
Weak transcription ZNF genes & repeats Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|